Creative Biolabs makes a breakthrough in guinea pig monoclonal antibody production service via hybridoma technology. Contrary to the disappointing rabbit hybridoma technology which has generally indicated low stability and productivity, our cutting-edge Guinea Pig Hybridoma technique exploits a novel source of outbreeding non-murine immune repertoire with stable productivity.